Related Experiment Video
Updated: Jun 8, 2025

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Modeling of skeletal development and diseases using human pluripotent stem cells
Hironori Hojo1,2, Shoichiro Tani3, Shinsuke Ohba4
1Division of Clinical Biotechnology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Human skeletal development involves distinct embryonic origins and signaling pathways. Human pluripotent stem cell (hPSC) models now recapitulate skeletal development, metabolism, and diseases for precision medicine applications.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Human skeletal elements originate from diverse embryonic sources, including neural crest, paraxial mesoderm, and lateral plate mesoderm.
- Skeletal development is a complex process orchestrated by coordinated signaling pathways during distinct embryonic stages.
Purpose of the Study:
- To review current understanding of embryonic skeletal development.
- To introduce state-of-the-art human pluripotent stem cell (hPSC) methods for modeling skeletal development, metabolism, and diseases.
- To discuss limitations and future perspectives of hPSC-based skeletal modeling in precision medicine.
Main Methods:
- Utilizing human pluripotent stem cells (hPSCs) to model skeletal development.
- Employing stepwise protocols to generate skeletal cells mimicking developmental pathways.
- Applying organoid methods for multicellular organization and recapitulation of skeletal development and metabolism.
- Modeling genetic skeletal diseases using patient-derived induced pluripotent stem cells and genome editing.
Main Results:
- Established hPSC-based models effectively recapitulate key aspects of skeletal development.
- Organoid systems allow for the study of complex multicellular skeletal organization and metabolism.
- Patient-derived iPSC models coupled with genome editing enable the study of skeletal diseases.
- Model-based drug screening platforms are emerging as powerful tools for therapeutic development.
Conclusions:
- hPSC-based modeling systems offer significant potential for advancing the understanding and treatment of skeletal disorders.
- Future applications in precision medicine are anticipated, leveraging these advanced modeling techniques.
- Continued research is crucial to overcome current limitations and fully realize the potential of hPSC-based skeletal modeling.
Related Concept Videos
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Somatic...
Stem Cell Culture
iPS Cell Differentiation

